TITLE

Activation and Coagulation Biomarkers Are Independent Predictors of the Development of Opportunistic Disease in Patients with HIV Infection

AUTHOR(S)
Alison J. Rodger; Fox, Zoe; Lundgren, Jens D.; Kuller, Lewis H.; Boesecke, Christoph; Gey, Daniela; Skoutelis, Athanassios; Goetz, Matthew Bidwell; Phillips, Andrew N.
PUB. DATE
September 2009
SOURCE
Journal of Infectious Diseases;9/15/2009, Vol. 200 Issue 6, p973
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Activation and coagulation biomarkers were measured within the Strategies for Management of Antiretroviral Therapy (SMART) trial. Their associations with opportunistic disease (OD) in human immunodeficiency virus (HIV)-positive patients were examined. Methods. Inflammatory (high-sensitivity C-reactive protein [hsCRP], interleukin-6 [IL-6], amyloid-A, and amyloid-P) and coagulation (D-dimer and prothrombin-fragment 1+2) markers were determined. Conditional logistic regression analyses were used to assess associations between these biomarkers and risk of OD. Results. The 91 patients who developed an OD were matched to 182 control subjects. Patients with an hsCRP level ⩾5 mg/mL at baseline had a 3.5 higher odds of OD (95% confidence interval [CI], 1.5-8.1) than did those with an hsCRP level <1 μg/mL (Pp.003, by test for trend) and patients with an IL-6 level ⩾3 pg/mL at baseline had a 2.4 higher odds of OD (95% CI, 1.0-5.4) than did those with an IL-6 level <1.5 pg/mL (P = .02, by test for trend). No other baseline biomarkers predicted development of an OD. Latest follow-up hsCRP level for those with an hsCRP level ⩾5 mg/mL (compared with a level <1 μg/mL; odds ratio [OR], 7.6; 95% CI, 2.0-28.5; Pp .002, by test for trend), latest amyloid-A level for those with an amyloid-A level ⩾6 mg/L (compared with a level <2 μg/L; OR, 3.8; 95% CI, 1.1-13.4; P =.03, by test for trend), and latest IL-6 level for those with an IL-6 level ⩾3 pg/mL (compared with a level <1.5 pg/mL; OR 2.4; 95% CI, 0.7-8.8; P =.04, by test for trend) were also associated with development of an OD. Conclusions. Higher IL-6 and hsCRP levels independently predicted development of OD. These biomarkers could provide additional prognostic information for predicting the risk of OD. Clinical trials registration. Clinical Trials.gov number NCT00027352.
ACCESSION #
44249942

 

Related Articles

  • Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection. Borges, Álvaro H.; O'Connor, Jemma L.; Phillips, Andrew N.; Neaton, James D.; Grund, Birgit; Neuhaus, Jacqueline; Vjecha, Michael J.; Calmy, Alexandra; Koelsch, Kersten K.; Lundgren, Jens D.; INSIGHT SMART Study and ESPRIT Groups // Journal of Infectious Diseases;8/1/2016, Vol. 214 Issue 3, p408 

    Background: Interleukin 6 (IL-6), high-sensitivity C-reactive protein (hsCRP), and D-dimer levels are linked to adverse outcomes in human immunodeficiency virus (HIV) infection, but the strength of their associations with different clinical end points warrants...

  • COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Dickens, Jennifer A.; Miller, Bruce E.; Edwards, Lisa D.; Silverman, Edwin K.; Lomas, David A.; Tal-Singer, Ruth // Respiratory Research;Nov2011, Vol. 12 Issue 11, p1 

    Background: There is a need for biomarkers to better characterise individuals with COPD and to aid with the development of therapeutic interventions. A panel of putative blood biomarkers was assessed in a subgroup of the Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE)...

  • Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease. Ledwaba, Lotty; Tavel, Jorge A.; Khabo, Paul; Maja, Patrick; Qin, Jing; Sangweni, Phumele; Liu, Xiao; Follmann, Dean; Metcalf, Julia A.; Orsega, Susan; Baseler, Beth; Neaton, James D.; Lane, H. Clifford // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: Levels of high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and D-dimer predict mortality in HIV patients on antiretroviral therapy (ART) with relatively preserved CD4+ T cell counts. We hypothesized that elevated pre-ART levels of these markers among patients with...

  • Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease. Ledwaba, Lotty; Tavel, Jorge A.; Khabo, Paul; Maja, Patrick; Qin, Jing; Sangweni, Phumele; Liu, Xiao; Follmann, Dean; Metcalf, Julia A.; Orsega, Susan; Baseler, Beth; Neaton, James D.; Lane, H. Clifford // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: Levels of high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and D-dimer predict mortality in HIV patients on antiretroviral therapy (ART) with relatively preserved CD4+ T cell counts. We hypothesized that elevated pre-ART levels of these markers among patients with...

  • Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease. Ledwaba, Lotty; Tavel, Jorge A.; Khabo, Paul; Maja, Patrick; Qin, Jing; Sangweni, Phumele; Liu, Xiao; Follmann, Dean; Metcalf, Julia A.; Orsega, Susan; Baseler, Beth; Neaton, James D.; Lane, H. Clifford // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Background: Levels of high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and D-dimer predict mortality in HIV patients on antiretroviral therapy (ART) with relatively preserved CD4+ T cell counts. We hypothesized that elevated pre-ART levels of these markers among patients with...

  • Inflammation in Chronic HIV Infection: What Can We Do? Erlandson, Kristine M.; Campbell, Thomas B. // Journal of Infectious Diseases;8/1/2015, Vol. 212 Issue 3, p339 

    The authors comment on a study published in this issue of the journal which addressed the impact of initial antiretroviral regimen choices on subsequent changes in inflammation and immune activation markers among HIV-infected persons. C-reactive protein, interleukin 6 and tumor necrosis factor...

  • Plasma Biomarkers for Detecting Hodgkin's Lymphoma in HIV Patients. Varnum, Susan M.; Webb-Robertson, Bobbie-Jo M.; Hessol, Nancy A.; Smith, Richard D.; Zangar, Richard C. // PLoS ONE;2011, Vol. 6 Issue 12, p1 

    The lifespan of people with human immunodeficiency virus (HIV) infection has increased as a result of effective antiretroviral therapy, and the incidences of the AIDS-defining cancers, non-Hodgkin's lymphoma and Kaposi sarcoma, have declined. Even so, HIV-infected individuals are now at greater...

  • Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection. Kuller, Lewis H.; Tracy, Russell; Belloso, Waldo; de Wit, Stephane; Drummond, Fraser; Lane, H. Clifford; Ledergerber, Bruno; Lundgren, Jens; Neuhaus, Jacqueline; Nixon, Daniel; Paton, Nicholas I.; Neaton, James D. // PLoS Medicine;Oct2008, Vol. 5 Issue 10, p1496 

    Background In the Strategies for Management of Anti-Retroviral Therapy trial, all-cause mortality was higher for participants randomized to intermittent, CD4-guided antiretroviral treatment (ART) (drug conservation [DC]) than continuous ART (viral suppression [VS]). We hypothesized that...

  • Adherence to Antiretroviral Therapy: How Much Is Enough? Gulick, Roy M. // Clinical Infectious Diseases;10/1/2006, Vol. 43 Issue 7, p942 

    The article presents a study on the efficiency of the antiretroviral therapy. It has been stated that the development of effective antiretroviral therapy in the resulted to significant virologic suppression and immune reconstitution and resulted in dramatic reductions in HIV-related morbidity...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics